Frost & Sullivan selected Raytel Cardiac Services as the recipient of the 2007 U.S. Cardiovascular Enabling Technology of the Year Award for its dedicated efforts in the remote home reporting market for cardiac rhythm technologies.

With the historic rise in chronic cardiac rhythm diseases, rising patient demand is poised to create an immense strain on the healthcare industry. Hospitals and private clinics realize that their trained specialists and physicians have progressively less time to spend with patients.

Additionally, in light of recent device failures and recalls as more and more devices are implanted, the ability to monitor patient health and device efficiency will prove to be of critical concern.

“Any refinement of procedures or devices that are able to expedite the time a doctor is able to allot for a patient, without sacrificing accuracy or thoroughness, will be seen as a significant advancement,” says Frost & Sullivan Research Analyst Venkat Rajan. “Raytel’s advanced remote home monitoring technologies and reporting services are aiding this market.”

Raytel is one of the most experienced telemedicine providers in the industry. Its technicians and report data are available to patients and clinicians 24/7 all year round.

The company’s highly experienced technical staff supports the monitoring service, provides comprehensive and relevant test reports, supports physician emergency notification requirements, works with patients to ensure test compliance with their physician’s prescribed frequency, and also offers guidance and training to both clinicians and patients. This comprehensive monitoring service allows the clinician to spend limited clinical resources on more acute patient needs without sacrificing quality of care.

“Raytel’s technology and services also represent significant future savings for reimbursement payers,” notes Rajan. “Being able to monitor patients on a frequent and consistent basis reduces the necessity of office visits, and even can pre-warn healthcare providers about delineating conditions that could lead to an acute emergency.”

Post event care is always more expensive than diagnosing and addressing an issue before it reaches a tipping point. Acute traumatic events usually require trips to the emergency room, extended hospital stays, and could even result in long term disability.

Another distinct advantage of a remote monitoring system, pertains to patients who live in remote or rural locations without immediate access to their cardiologist. Not only can the device alert the cardiologist of unstable arrhythmias, but they can also monitor device function, battery power, and identify if cardiac leads have become disconnected.

In the health care industry there is no more valuable commodity than time. The most accurate and timely detection of life threatening events is critical to initiating therapy. The horizon of implantable therapeutic medical device technology will be in the universal adaptation of accurate real time telemonitoring of all patients, in order to ensure that they receive the best care possible.

For its efforts in helping to pioneer this industry’s efforts, Raytel is the 2007 recipient of the Frost & Sullivan Enabling Technology of the Year Award.

Each year Frost & Sullivan presents this Award to a company that has developed a technology that can benefit or revolutionize the industry. The Award recipient has developed a system or enabling component of a system that removes a significant stumbling block in the development of technology.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com/ or http://www.healthcare.frost.com/.

Related Health News:

1. Frost & Sullivan Recognizes A&D Medical’s Technological Excellence in Advanced Blood Pressure Monitoring Solutions Frost & Sullivan has selected A&D Medical / LifeSource as the recipient of the 2007 Excellence in Technology of the Year Award in the North...
2. Frost & Sullivan Recognizes Aesculap Academy for Efforts to Offer Premium Medical Education Frost & Sullivan has selected Aesculap Academy as the recipient of the 2007 Frost & Sullivan Global Medical Professional Education Institution of the Year Award....
3. Signalife Submits Fidelity 200 Cardiac Event Recorder Pre-Market Notification to FDA GREENVILLE, S.C., May 3 /PRNewswire-FirstCall/ -- Signalife, Inc. (AMEX:SGN) has announced that it has submitted its Fidelity 200 Cardiac Event Recorder 510K pre-market notification to...
4. Study Shows Masimo Blue Sensor Most Accurate in Monitoring Cyanotic Infants A study presented at the Society for Critical Care Medicine's 2007 annual meeting concludes that the Masimo Blue sensor is superior in continuous and accurate...
5. Discussion on Artery Diseases in American Indians and Native Americans There apparently is an issue with Coronary artery disease--it is the leading cause of death of American Indians in the United States and needs to...